'Onset diabetes' presentation slideshows

Double Trouble: HTN plus Dyslipidemia Aggressive Management in Primary Care

Double Trouble: HTN plus Dyslipidemia Aggressive Management in Primary Care. Amelie Hollier, DNP, FNP-BC, FAANP Advanced Practice Education Associates. Fatty Streak. Intracellular lipids and extracellular deposits make up the fatty streak Macrophages are part of the inflammatory process

1.03k views • 91 slides

The neonate (newborn) comes into the world after the process of labor:

473 views • 33 slides

IN ternational VE rapamil SR and Trandolapril ST udy

IN ternational VE rapamil SR and Trandolapril ST udy. Principal Investigator: Carl J. Pepine, MD Division of Cardiovascular Medicine University of Florida College of Medicine Gainesville, Florida USA. 03J-615-9937-4. What Is INVEST?.

404 views • 25 slides

Prevention of Diabetes Mellitus

Prevention of Diabetes Mellitus. Prof. Adel El-Etriby Professor of Cardiology Ain Shams Faculty of Medicine. Rationale for Prevention. The incidence of type 2 of diabetes is increasing in epidemic proportions throughout the world. Once type 2 diabetes develops, it is difficult to treat.

1.65k views • 22 slides

PPAR ? activation Impact on pathways of clinical care

PPAR ? activation Impact on pathways of clinical care. New paradigm of multiple risk factormanagement. The future of drug therapy belongs to prevention, which is just now being addressed, and to intensive management of all cardiovascular risk factors.

664 views • 21 slides

Carl J. Pepine, MD, MACC Division of Cardiovascular Medicine

Morbidity and Mortality in Contemporary CAD Patients With Hypertension Treated With Either a Verapamil/Trandolapril or Beta-Blocker/Diuretic Strategy (INVEST): Main Outcomes, Predictors of Risk, Diabetes, New Diabetes, BP and Depression/QoL Sub-analyses.

219 views • 20 slides

Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial

Determinants of new onset diabetes among hypertensive patients randomised in the ASCOT-BPLA Trial. Dr Ajay K Gupta International Centre for Circulatory Health NHLI, Imperial College London. Presented on behalf of the ASCOT Investigators. Background.

188 views • 15 slides

195 views • 2 slides

TKOvalueash

VALUE: New-onset diabetes in an amlodipine-based vs valsartan-based therapy in high-risk hypertensives. Jamerson KA. American Hypertension Society 20th Annual Scientific Session; May 14-18, 2005; San Francisco, CA.

93 views • 1 slides